- Home
- NTRA vs SWK Comparison
NTRA vs SWK Comparison
Compare NTRA & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- SWK
- Stock Information
- Founded
- NTRA 2003
- SWK 1843
- Country
- NTRA United States
- SWK United States
- Employees
- NTRA N/A
- SWK N/A
- Industry
- NTRA Medical Specialities
- SWK Industrial Machinery/Components
- Sector
- NTRA Health Care
- SWK Consumer Discretionary
- Exchange
- NTRA Nasdaq
- SWK Nasdaq
- Market Cap
- NTRA 20.6B
- SWK 13.8B
- IPO Year
- NTRA 2015
- SWK N/A
- Fundamental
- Price
- NTRA $159.83
- SWK $80.05
- Analyst Decision
- NTRA Strong Buy
- SWK Hold
- Analyst Count
- NTRA 15
- SWK 8
- Target Price
- NTRA $152.67
- SWK $100.00
- AVG Volume (30 Days)
- NTRA 1.1M
- SWK 1.7M
- Earning Date
- NTRA 02-26-2025
- SWK 02-05-2025
- Dividend Yield
- NTRA N/A
- SWK 4.08%
- EPS Growth
- NTRA N/A
- SWK N/A
- EPS
- NTRA N/A
- SWK N/A
- Revenue
- NTRA $1,531,955,000.00
- SWK $15,381,700,000.00
- Revenue This Year
- NTRA $53.71
- SWK N/A
- Revenue Next Year
- NTRA $11.00
- SWK $1.92
- P/E Ratio
- NTRA N/A
- SWK N/A
- Revenue Growth
- NTRA 54.94
- SWK N/A
- 52 Week Low
- NTRA $58.53
- SWK $77.70
- 52 Week High
- NTRA $175.63
- SWK $110.88
- Technical
- Relative Strength Index (RSI)
- NTRA 51.07
- SWK 37.85
- Support Level
- NTRA $155.12
- SWK $78.90
- Resistance Level
- NTRA $161.53
- SWK $81.47
- Average True Range (ATR)
- NTRA 5.56
- SWK 1.66
- MACD
- NTRA -1.63
- SWK 0.28
- Stochastic Oscillator
- NTRA 37.59
- SWK 39.94
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.